Append Medical

company

About

Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$7.40M
Industries
Health Care,Medical,Medical Device,mHealth
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.

The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growing segment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$7.40M
Append Medical has raised a total of $7.40M in funding over 2 rounds. Their latest funding was raised on Aug 4, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 4, 2021 Series A $7.40M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Append Medical is funded by 1 investors. Boston Scientific are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific Series A